MC2 CEO exit raises questions about capital raising and strategy change

Previous Chief Executive Officer Jesper J. Lange’s pharmaceutical endeavor was bypassed when MC2 made executive modifications– in spite of an earlier strategy to elevate USD 90m to create a medicine.

发布者:BY ELLEN BIRKNER,转转请注明出处:https://robotalks.cn/mc2-ceo-exit-raises-questions-about-capital-raising-and-strategy-change/

(0)
上一篇 6 6 月, 2025 8:19 上午
下一篇 6 6 月, 2025

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。